Company Filing History:
Years Active: 2016
Title: Stefania Tiddia: Innovator in Anticoagulant Research
Introduction
Stefania Tiddia is a prominent inventor based in Modena, Italy. She has made significant contributions to the field of anticoagulant research, particularly through her innovative work on chemically modified heparins. Her research has important implications for medical treatments, including the potential treatment of malaria.
Latest Patents
Stefania Tiddia holds a patent for "Low anticoagulant heparins." This invention relates to a chemically modified heparin that exhibits an antifactor II activity of less than 10 IU/mg and an antifactor Xa activity of less than 10 IU/mg. The average molecular weight of this heparin is between about 6.5 and 9.5 kDa. The patent also discloses a method for preparing the heparin and outlines its medical uses.
Career Highlights
Stefania is currently associated with Dilaforette AB, where she continues her research and development in the field of anticoagulants. Her work has garnered attention for its innovative approach and potential applications in medicine.
Collaborations
Stefania has collaborated with notable professionals in her field, including Hans-Peter Ekre and Ulf Lindahl. These collaborations have further enriched her research and contributed to advancements in anticoagulant therapies.
Conclusion
Stefania Tiddia is a trailblazer in the field of anticoagulant research, with her innovative patent on low anticoagulant heparins paving the way for new medical treatments. Her contributions are vital to the ongoing development of effective therapies.